Screener
Bio-Techne Corp. TECH EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne Corp. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Bio-Techne Corp.’s 10-K, filed August 24, 2026.
- Filed
- Aug 24, 2026, 4:31 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001104659-26-100322
| Line item | Year Ended June 30, 2026 | Year Ended June 30, 2025 | Year Ended June 30, 2024 |
|---|---|---|---|
| Other comprehensive income (loss) | (10,700) | 18,436 | (12,252) |
| Comprehensive income | $171,162 | $91,836 | $155,853 |
| Earnings per share: | |||
| Basic | $1.17 | $0.47 | $1.07 |
| Diluted | $1.16 | $0.46 | $1.05 |
| Weighted average common shares outstanding: | |||
| Basic | 155,963 | 157,521 | 157,708 |
| Diluted | 157,009 | 159,717 | 160,774 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Bio-Techne Corp.'s EPS (diluted)?
- Bio-Techne Corp. (TECH) reported EPS (diluted) of $0.35 in Q2 2026.
- What is the long-term trend for Bio-Techne Corp.'s EPS (diluted)?
- Over 3 years (2022 to 2026), Bio-Techne Corp.'s EPS (diluted) has grown at a -26.8% compound annual growth rate (CAGR), from $2.93 to $1.15.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Bio-Techne Corp.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude